Entering text into the input field will update the search result below

Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q1 2020 Results - Earnings Call Transcript

May 06, 2020 8:32 PM ETBio-Rad Laboratories, Inc. (BIO), BIO.B
SA Transcripts profile picture
SA Transcripts

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2020 Earnings Conference Call May 6, 2020 5:00 PM ET

Company Participants

Ron Hutton - Vice President and Treasurer

Norman Schwartz - Chief Executive Officer

Ilan Daskal - Executive Vice President and Chief Financial Officer

Andy Last - Executive Vice President and Chief Operating Officer

Annette Tumolo - President of Life Science Group

Dara Wright - President of the Clinical Diagnostics Group

Conference Call Participants

Brandon Couillard - Jefferies

Patrick Donnelly - Citigroup

Dan Leonard - Wells Fargo


Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Bio-Rad Laboratories Incorporated Earnings Conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Thank you.

I would now like to hand the call over to your speaker today, Mr. Ron Hutton. Please go ahead.

Ron Hutton

Thank you, Buena. Good afternoon, and thank you all for joining us. Today, we will review the first quarter results for 2020. With me on the phone are, Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Annette Tumolo, President of Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters. These statements are based on assumptions and expectations of future events that are subject to risk and uncertainties. Included in these forward-looking statements, our statements regarding the impact of the COVID-19 pandemic on Bio-Rad results and operations and steps Bio-Rad is taking and response to the pandemic.

Our actual results may differ

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About BIO

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BIO

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.